DNA synthesis company
Ribbon Biolabs has raised €18M across 1 funding round from 5 investors, most recently a Series A round in Jan 2022. Based in Vienna, Austria; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-01-31 | Series A | €18M |
| Hadean Ventures,Helicase Venture,IST cube,Lansdowne Partners,Tecnet equity |
| View deal → |
